{"id":"https://openalex.org/W4306728554","doi":"https://doi.org/10.1161/circoutcomes.122.009399","title":"Therapeutic Inertia in Lipid-Lowering Treatment Intensification: Digital Tools and Performance Management to the Rescue?","display_name":"Therapeutic Inertia in Lipid-Lowering Treatment Intensification: Digital Tools and Performance Management to the Rescue?","publication_year":2022,"publication_date":"2022-10-18","ids":{"openalex":"https://openalex.org/W4306728554","doi":"https://doi.org/10.1161/circoutcomes.122.009399","pmid":"https://pubmed.ncbi.nlm.nih.gov/36256462"},"language":"en","primary_location":{"id":"doi:10.1161/circoutcomes.122.009399","doi":"https://doi.org/10.1161/circoutcomes.122.009399","is_oa":false,"landing_page_url":"https://doi.org/10.1161/circoutcomes.122.009399","pdf_url":null,"source":{"id":"https://openalex.org/S52278559","display_name":"Circulation Cardiovascular Quality and Outcomes","issn_l":"1941-7705","issn":["1941-7705","1941-7713"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation: Cardiovascular Quality and Outcomes","raw_type":"journal-article"},"volume":null,"type":"editorial","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072663918","display_name":"Khurram Nasir","orcid":"https://orcid.org/0000-0001-5376-2269","observed_orcids":["https://orcid.org/0000-0001-5376-2269","https://orcid.org/0000-0002-2632-1318"]},"institutions":[{"id":"https://openalex.org/I1295876152","display_name":"Houston Methodist","ror":"https://ror.org/027zt9171","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1295876152"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Khurram Nasir","raw_affiliation_strings":["Center for Cardiovascular Computational and Precision Health (C3-PH), Houston Methodist, Houston, TX (K.N.)","Division of Cardiovascular Prevention and Wellness, Houston Methodist DeBakey Heart and Vascular Center, TX (K.N.)"],"raw_orcid":"https://orcid.org/0000-0001-5376-2269","affiliations":[{"raw_affiliation_string":"Center for Cardiovascular Computational and Precision Health (C3-PH), Houston Methodist, Houston, TX (K.N.)","institution_ids":["https://openalex.org/I1295876152"]},{"raw_affiliation_string":"Division of Cardiovascular Prevention and Wellness, Houston Methodist DeBakey Heart and Vascular Center, TX (K.N.)","institution_ids":["https://openalex.org/I1295876152"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5056552067","display_name":"Joseph Salami","orcid":"https://orcid.org/0000-0002-9310-9480","observed_orcids":["https://orcid.org/0000-0002-9310-9480"]},"institutions":[{"id":"https://openalex.org/I63772739","display_name":"Florida Atlantic University","ror":"https://ror.org/05p8w6387","country_code":"US","type":"education","lineage":["https://openalex.org/I63772739"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph A. Salami","raw_affiliation_strings":["Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton (J.A.S.)","Joseph A. Salami Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton (J.A.S.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton (J.A.S.)","institution_ids":["https://openalex.org/I63772739"]},{"raw_affiliation_string":"Joseph A. Salami Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton (J.A.S.)","institution_ids":["https://openalex.org/I63772739"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5072663918"],"corresponding_institution_ids":["https://openalex.org/I1295876152"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":7,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"15","issue":"12","first_page":"e009399","last_page":"e009399"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10193","display_name":"Coronary Interventions and Diagnostics","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14212","display_name":"Health Promotion and Cardiovascular Prevention","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/therapeutic-inertia","display_name":"therapeutic inertia","score":0.996999979019165},{"id":"https://openalex.org/keywords/high-intensity-statins","display_name":"high-intensity statins","score":0.9850000143051147},{"id":"https://openalex.org/keywords/pcsk9-inhibitors","display_name":"PCSK9 inhibitors","score":0.7459999918937683},{"id":"https://openalex.org/keywords/atherosclerotic-cardiovascular-disease","display_name":"atherosclerotic cardiovascular disease","score":0.7940000295639038},{"id":"https://openalex.org/keywords/ldl-cholesterol-lowering","display_name":"LDL cholesterol lowering","score":0.875},{"id":"https://openalex.org/keywords/digital-health-tools","display_name":"digital health tools","score":0.6869999766349792},{"id":"https://openalex.org/keywords/performance-management","display_name":"performance management","score":0.9580000042915344},{"id":"https://openalex.org/keywords/secondary-prevention","display_name":"secondary prevention","score":0.5979999899864197},{"id":"https://openalex.org/keywords/acute-coronary-syndrome","display_name":"acute coronary syndrome","score":0.703000009059906},{"id":"https://openalex.org/keywords/myocardial-infarction","display_name":"myocardial infarction","score":0.7730000019073486},{"id":"https://openalex.org/keywords/revascularization","display_name":"revascularization","score":0.8220000267028809}],"concepts":[{"id":"https://openalex.org/C110407247","wikidata":"https://www.wikidata.org/wiki/Q122508","display_name":"Inertia","level":2,"score":0.7151575088500977},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.32811784744262695},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.11722144484519958},{"id":"https://openalex.org/C74650414","wikidata":"https://www.wikidata.org/wiki/Q11397","display_name":"Classical mechanics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069438","descriptor_name":"Ezetimibe","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008055","descriptor_name":"Lipids","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1161/circoutcomes.122.009399","doi":"https://doi.org/10.1161/circoutcomes.122.009399","is_oa":false,"landing_page_url":"https://doi.org/10.1161/circoutcomes.122.009399","pdf_url":null,"source":{"id":"https://openalex.org/S52278559","display_name":"Circulation Cardiovascular Quality and Outcomes","issn_l":"1941-7705","issn":["1941-7705","1941-7713"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation: Cardiovascular Quality and Outcomes","raw_type":"journal-article"},{"id":"pmid:36256462","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36256462","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation. Cardiovascular quality and outcomes","raw_type":"Editorial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":9,"referenced_works":["https://openalex.org/W2552545843","https://openalex.org/W2596179513","https://openalex.org/W2899997727","https://openalex.org/W2900034165","https://openalex.org/W3102591862","https://openalex.org/W3121215950","https://openalex.org/W3201886037","https://openalex.org/W4285402159","https://openalex.org/W4306167581"],"related_works":["https://openalex.org/W4404324337","https://openalex.org/W4392656167","https://openalex.org/W3022919671","https://openalex.org/W4404341210","https://openalex.org/W4410850269","https://openalex.org/W4385477314","https://openalex.org/W2983052551","https://openalex.org/W4312019673","https://openalex.org/W4220771406","https://openalex.org/W3099857364"],"abstract_inverted_index":{"therosclerotic":[0],"cardiovascular":[1,171],"disease":[2,43],"(ASCVD)":[3],"continues":[4],"to":[5,176,244],"be":[6],"the":[7,21,26,52,105,216,221],"leading":[8],"cause":[9],"of":[10,16,39,54,62,110,153],"death":[11],"and":[12,18,24,41,87,94,150,204],"a":[13,48,79,89,167],"substantial":[14],"source":[15],"morbidity":[17],"disability":[19],"in":[20,51,57,65,84,125,145,215,234],"United":[22,106],"States":[23],"across":[25],"world.Since":[27],"hyperlipidemia":[28],"considerably":[29],"increases":[30],"ASCVD":[31,69,113],"risk,":[32],"lipid-lowering":[33],"treatments":[34],"(LLTs)":[35],"have":[36,74,165],"become":[37],"pillars":[38],"primary":[40],"secondary":[42],"prevention.Although":[44],"there":[45,120],"has":[46,70],"been":[47],"steady":[49],"increase":[50],"use":[53],"evidence-based":[55],"statins":[56,64,129],"recent":[58,202],"years,":[59],"maximizing":[60],"adoption":[61],"high-intensity":[63,96,115],"those":[66,200],"with":[67,103,112,173,201],"established":[68],"remained":[71],"suboptimal.Previously,":[72],"we":[73],"shown":[75],"that":[76,195],"despite":[77],"being":[78],"class":[80],"IA":[81],"recommendation,":[82],"available":[83],"generic":[85],"form":[86],"at":[88],"low":[90],"out-of-pocket":[91],"cost,":[92],"statins,":[93,97],"particularly":[95],"are":[98],"substantially":[99],"underused":[100],"among":[101,207],"individuals":[102],"ASCVD.In":[104],"States,":[107],"only":[108],"28%":[109],"patients":[111],"reported":[114],"statin":[116],"usage.":[117],"1":[118],"Although":[119],"is":[121,213],"room":[122],"for":[123,170,210],"improvement":[124],"appropriate":[126],"maximally":[127],"tolerated":[128],"uptake,":[130],"data":[131],"from":[132,191,224],"2":[133],"large":[134],"clinical":[135],"trials":[136,193],"(FOURIER":[137],"[Further":[138],"Cardiovascular":[139,154],"Outcomes":[140,155],"Research":[141],"With":[142,147,163],"PCSK9":[143],"Inhibition":[144],"Subjects":[146],"Elevated":[148],"Risk]":[149],"ODYSSEY":[151],"[Evaluation":[152],"After":[156],"an":[157],"Acute":[158],"Coronary":[159],"Syndrome":[160],"During":[161],"Treatment":[162],"Alirocumab])":[164],"demonstrated":[166],"reduced":[168],"risk":[169,197,209],"events":[172,212],"additional":[174],"50%":[175],"60%":[177],"LDL":[178],"lowering":[179],"by":[180],"proprotein":[181],"convertase":[182],"subtilisin/kexin":[183],"type":[184],"9":[185],"serine":[186],"protease":[187],"inhibitors.2,3":[188],"Secondary":[189],"analyses":[190],"these":[192],"showed":[194],"higher":[196],"subgroups,":[198],"including":[199],"revascularization":[203],"myocardial":[205],"infarction,":[206],"whom":[208],"recurrent":[211],"highest":[214],"first":[217],"year,":[218],"may":[219],"derive":[220],"greatest":[222],"benefits":[223],"intensive":[225],"LDL-C":[226],"(low-density":[227],"lipoprotein":[228],"cholesterol)-lowering":[229],"therapies.Contemporary":[230],"LLT":[231],"intensification":[232],"trends":[233],"this":[235],"important":[236],"high-risk":[237],"category":[238],"have,":[239],"however,":[240],"received":[241],"little":[242],"attention":[243],"date.":[245]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2022-10-19T00:00:00"}